Clinical Trials

40 enrolled

Recurrence, Small Cell Lung Carcinoma

NCT07531095 2026-04-15

DeLLphi-313

160 enrolled

Small Cell Lung Carcinoma

NCT06982222 2026-04-13

Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones

BreastGenitourinaryThoracic

24 enrolled

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Prostatic Neoplasms

NCT07523464 2026-04-13

Centrally Confined 8Gy/1f to Tumor Core Followed by Concurrent Chemoradiotherapy for Unresectable Stage III NSCLC

24 enrolled

Locally-Advanced Non-Small Cell Lung Cancer

NCT07519655 2026-04-09

Phase 1 Study of PF-08046033 in Advanced Solid Tumors

DermatologicGastrointestinalThoracic

250 enrolled

Esophageal Neoplasms, Lung Neoplasms, Melanoma

NCT07488923 2026-04-01

SPECTRAL-1

110 enrolled

EndocrineThoracic

Carcinoma, Neuroendocrine, Small Cell Lung Carcinoma

NCT07495098 2026-03-27

Phase 1B Trial of Intratumoral Cisplatin for Stage IV Lung Cancer

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07391670 2026-03-12

IMFINZI-subQ

40 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Hepatocellular, Small Cell Lung Carcinoma

NCT07461727 2026-03-10

An Open-Label, Single-Arm, Dose-Escalation Phase I Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of EDB-102 in Patients With EGFR L858R-Mutant, Third-Generation TKI-Resistant Advanced Non-Small Cell Lung Cancer With Liver Metastases

15 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07231445 2026-03-04

Study of ZG006 in Combination With PD-1/PD-L1 Immune Checkpoint Inhibitors as First-Line Standard Therapy in Participants With Extensive Stage Small-Cell Lung Cancer

100 enrolled

Small Cell Lung Carcinoma

NCT07436858 2026-02-27

Whole Body HER2 Quantification With 89Zr-Trastuzumab PET/CT to Asses Zr-trastuzumab Accumulation in HER2-mutated and HER2-overexpressing Metastatic Non-small Cell Lung Cancer

20 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07272642 2026-02-25

DUNP19

BreastGastrointestinalHead & NeckThoracic

16 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms, Triple Negative Breast Neoplasms

NCT07382726 2026-02-20

Phase 1 Study Of Izalontamab Brengitecan + Adagrasib In NSCLC - The IZA-A Trial

18 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07423117 2026-02-20

A Study of ITC-6146RO in Patients With Advanced or Metastatic Cancer Who Have Failed Standard Therapy

102 enrolled

BreastThoracic

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Triple Negative Breast Neoplasms

NCT07416695 2026-02-18

A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HLX3901 in Patients With Advanced SCLC or NEC

138 enrolled

SCLC

NCT07414953 2026-02-17

A Phase Ib Study of HS-10504 Combined Therapy in NSCLC

400 enrolled

Lung Neoplasms

NCT04266730 2026-01-28

PANDA-VAC

6 enrolled

Head & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Lung Neoplasms

NCT07358884 2026-01-22

First in Human Study of QLS5316 in Solid Tumors

GastrointestinalHead & NeckThoracic

300 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Stomach Neoplasms, Colorectal Neoplasms

NCT07351565 2026-01-20

CPPGPTCLC

22 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07318636 2026-01-06

NK-cell Therapy Combined With PD-1 Antibody and Platinum-Based Chemotherapy as Neoadjuvant Therapy in Resectable NSCLC

10 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07249879 2025-11-25

This Study is an Open-lable, Phase I Study to Evaluate the Safety, Feasibility, Cytokinetics, and Preliminary Efficacy of GC511B in DLL3+ Relapsed/Refractory Small Cell Lung Cancer.

55 enrolled

Small Cell Lung Carcinoma

NCT06897735 2025-11-18

EDDIS-a1

DermatologicHead & NeckThoracic

24 enrolled

Lung Neoplasms, Melanoma, Mouth Neoplasms

NCT07177937 2025-09-22

A Study of DXC014 in Patients With Advanced Solid Tumors.

DermatologicGenitourinaryThoracic

150 enrolled

Melanoma, Prostatic Neoplasms, Small Cell Lung Carcinoma

NCT07105176 2025-08-19

HS-IT101 Injection for Advanced NSCLC

Advanced Non-Small Cell Lung Cancer

NCT07117214 2025-08-12

A Phase I Study of [68Ga]Ga-DWJ155 in Patients With Breast and Lung Cancers

36 enrolled

BreastThoracic

Adenocarcinoma, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT07110363 2025-08-07

A Clinical Study of BT02 in Treating Patients With Advanced Lung Cancer

58 enrolled

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

NCT07073183 2025-07-18

Safety and Tolerability of CVHNLC Plus Pembrolizumab in Patients With Squamous Non Small-Cell Lung Cancer (sqNSCLC)

36 enrolled

Squamous NSCLC

NCT07063407 2025-07-14

Phase 1 Study of HS-20093 Combinations in Patients With Extensive Stage Small Cell Lung Cancer

50 enrolled

Extensive Stage Small Cell Lung Cancer (ES-SCLC)

NCT07036185 2025-06-25

A Clinical Trail of KJ015 in Patients With HER2-Expressing Solid Tumors

BreastGastrointestinalHead & NeckThoracic

66 enrolled

Squamous Cell Carcinoma of Head and Neck, Bile Duct Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms

NCT06966583 2025-05-12

NMN

20 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06963502 2025-05-09

A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Patients With Advanced Solid Tumors

762 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms

NCT06948539 2025-04-29

To Evaluate the Tolerability and Pharmacokinetics of TQB2101 for Injection in Patients With Advanced Malignant Tumors

BreastGastrointestinalThoracic

66 enrolled

Breast Neoplasms, Lung Neoplasms, Colorectal Neoplasms

NCT06934590 2025-04-23

Evaluate Safety and Tolerability of RX001 in Patients With KRAS Mutant Advanced NSCLC

18 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06936735 2025-04-20

Phase I Study of HS-20108 in Participants With Advanced Solid Tumors

502 enrolled

EndocrineThoracic

Carcinoma, Neuroendocrine, Small Cell Lung Carcinoma

NCT06823245 2025-02-12

Pharmacokinetic Study of HS-10241 Tablets in Subjects with Hepatic Impairment and Normal Hepatic Function

32 enrolled

Advanced Non-small Cell Lung Cancer

NCT06823258 2025-02-12

Pharmacokinetic Study of HS-10365 Capsule in Subjects with Hepatic Impairment and Normal Hepatic Function

32 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06760676 2025-01-07

A Multiple Tumor Species, Open and Multi-center Clinical Study of Alpaloritovorelli Antibodies (QL-1706) Combined with Pulsed Low Dose Rate External Irradiation (PLDR) for Disease Progression After Previous Anti-tumor Therapy

GastrointestinalGynecologicThoracic

90 enrolled

Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms

NCT06754761 2025-01-01

Human ADME Study of [14C]-Ceralasertib (AZD6738) and Absolute Bioavailability of Ceralasertib

8 enrolled

GynecologicThoracic

Carcinoma, Non-Small-Cell Lung, Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT06732258 2024-12-27

Low-dose Radiotherapy Combined with Concurrent Chemotherapy, Toripalimab and Tifcemalimab in the Treatment of ES-SCLC

Small Cell Lung Carcinoma

NCT06743555 2024-12-20

SAVED LUNG

14 enrolled

Pathologic Complete Response, Carcinoma, Non-Small-Cell Lung

NCT06652529 2024-11-07

AROG4-01-01

GastrointestinalGynecologicOther solid neoplasmThoracic

35 enrolled

Carcinoma, Non-Small-Cell Lung, Mesothelioma, Ovarian Neoplasms, Colorectal Neoplasms

NCT06641609 2024-10-15

A Phase I Study of CFT8919 in Patients With Advanced NSCLC

166 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06622174 2024-10-02

PROMISE

32 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Disease Progression

NCT06594874 2024-09-19

A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Participants with KRAS G12C Mutation Advanced Solid Tumors

350 enrolled

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

NCT06602661 2024-09-19

Reinforced and Non-Reinforced Staple Lines in Fissureless Lobectomy

65 enrolled

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06585059 2024-09-05

Clinical Trial of TQB2928 in Combination With a Third-Generation Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) in Patients With Advanced Non-Small Cell Lung Cancers

20 enrolled

Advanced Non-small Cell Lung Cancer

NCT06558175 2024-08-16

REPAIR

48 enrolled

GastrointestinalThoracic

Esophageal Neoplasms, Lung Neoplasms, Neoplasms

NCT06218940 2024-01-23

HY1272 in Patients With Locally Advanced or Metastatic Solid Tumors or Locally Advanced or Metastatic EGFRm+ NSCLC

40 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06107894 2023-10-30

TIL Therapy for Patients With Advanced Solid Tumors

Lung Neoplasms

NCT06067776 2023-10-05

Osimertinib, Cetuximab, and Tucatinib for the Treatment of EGFR-Mutant Stage IV or Recurrent Non-small Lung Cell Cancer

36 enrolled